shares rallied after it said it experienced strong growth in Consulting sales, with record levels of Consulting bookings in Q3 and Q4 to-date.
The cyber security services provider said that Consulting, Managed Services and Incident Response revenue in the third quarter experienced an organic growth rate of about 25%.
ECSC also said it continued recruitment of sales partners, with 87 partners generating over 100 new sales opportunities.
Shares in ECSC Group were trading 23.33% higher at 92.5p during Tuesday morning trading
Ian Mann, CEO of ECSC, commented: "We are delighted to report such strong return to growth, and positive cash-flows since our interims for H1.”
He said: “Despite some challenging UK economic conditions, the team has continued to win new clients, and deliver outstanding levels of client service, reflected in improved financial performance across the Group.”
He added: “The increasing levels of cyber breaches, and strong demand across all ECSC cyber security services, positions ECSC very well moving into 2020."
ECSC had £450,000 cash at 13 October 2019.
Follow News & Updates from ECSC here:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
SP Angel research note on commodities and miners, featuring: Ferro-Alloy Resources Limited (FAR LN) – Fall in vanadium pentoxide price prompts management to look for new funding Resolute Mining (RSG LN) – Bibiani review Sirius Minerals (SXX LN) – A Siriusly sorry Christmas Carol Vast Resources* (VAST LN) 0.29p, Mkt Cap £29m – Exposure to copper and rough diamonds in Romania and Zimbabwe
Colin Bird Executive Chairman of Xtract Resources (XTR) talks about the Alluvial Collaboration Agreement with Nexus and provides a general update Russ Mould, Investment Director at stockbroker AJ Bell talks about: the Election Result, Macro and UK stocks Alan Green talks about 4 stocks
Mammoth Biosciences is a US-based biotech company that developed the world's first CRISPR-based detection platform capable of sensing any biomarker or disease with DNA/RNA backed by investors that include Mayfield, NFX, 8VC, AME Cloud, Wireframe, Kairos, along with Tim Cook, Brook Byers, Bob Nelsen, and Jeff Huber.
“It has given us substantial financial flexibility at a highly competitive rate of interest in the last three years as we have successfully carried out our multi-well Niger drilling campaign and completed the Seven Energy transaction."
Tim McCarthy, Chairman of ImmuPharma (IMM) discusses the deal with US-based Avion Pharmaceuticals, the agreement with Lanstead Capital and what the future holds for ImmuPharma regarding new trial design as well as anticipated upcoming milestones.
The hedge fund owned by the billionaire investor and anti-Brexit donor George Soros has made a £16m bet against shares in the owner of the Daily Mail newspaper, Ocado has said its product range will be 50% bigger and offer lower prices and better quality products when it switches from Waitrose to Marks & Spencer next year,
SPAngel research note on commodities and miners, featuring: Base Resources (BSE LN) – Toliara DFS confirms PFS estimates Premier African Minerals* (PREM LN) – Fundraising Resolute Mining (RSG LN) – Drilling results from Tabakoroni